Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses

Journal of Clinical Pharmacy and Therapeutics

Volumn 27, Issue 2, 2002, Pages 143-150

  Chow, A T ^a   Chen, A ^a   Lattime, H ^a   Morgan, N ^a   Wong, F ^a   Fowler, C ^a   Williams, R R ^b  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b Asia Pacific   (Hong Kong)

Author keywords

Complicated skin infections; Complicated skin structure infections; Levofloxacin; Pharmacokinetics

Indexed keywords

LEVOFLOXACIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG PENETRATION; FEMALE; HUMAN; INFECTION COMPLICATION; MALE; NORMAL HUMAN; PLASMA; SKIN BIOPSY; SKIN INFECTION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; SKIN; SKIN DISEASES; TISSUE DISTRIBUTION;

EID: 0036253028     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2002.00396.x     Document Type: Article

References (34)

1. The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci
2. Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens
3. Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates
4. Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases
5. Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates
6. Levofloxacin: A review of its antibacterial activity
7. Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin
8. In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections
9. Antianaerobic activity of levofloxacin alone and combined with clindamycin and metronidazole
10. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
11. Once a day levofloxacin in the treatment of mild to moderate and severe community-acquired pneumonia in adults
12. Safety and efficacy of oral levofloxacin versus cefuroxime axetil in acute bacterial exacerbation of bronchitis
13. Multicenter, randomized study comparing efficacy and safety of oral levofloxacin and cefaclor in treatment of acute bacterial exacerbations of chronic bronchitis
14. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis
15. Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults
16. Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: A multi-centre, double-blind, randomized study
17. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults
18. Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections
19. A multicentre, double-blind, randomized study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections
20. A double-blind, randomized trial of the efficacy and safety of short-course, once-daily levofloxacin versus ofloxacin twice daily in uncomplicated urinary tract infections
21. A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection
22. Safety and efficacy of levofloxacin versus ciprofloxacin in complicated urinary tract infections in adults
23. Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis
24. Pharmacodynamics of levofloxacin: A new paradigm for early clinical trials
25. Application of fluoroquinolone pharmacodynamics
26. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers
27. Safety and pharmacokinetics of multiple 750 mg doses of intravenous levofloxacin in healthy volunteers
28. Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine
29. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects
30. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin
31. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid
32. Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid